Singapore Society of Haematology Annual Scientific Meeting 2026
Date:
9 May 2026 (Saturday)
Time:
08.00 - 17.15 hrs Singapore Time
Venue:
Level 1 Auditorium, NUHS Tower Block, 1E Kent Ridge Road, Singapore 119228
Welcome Message
Dear Colleagues,
We cordially invite you to the Singapore Society of Haematology Annual Scientific Meeting (SSH ASM 2026), which will be held on 9 May 2026 at the National University Health System Tower Block. This event is part of our ongoing efforts to promote advances in the knowledge and practice of haematology.
The Annual Scientific Meeting is a premier event that brings together leading experts, researchers, and practitioners in the field of haematology. It provides a unique platform for the exchange of ideas, presentation of the latest research findings, and discussion of innovative practices that can shape the future of haematology.
Furthermore, we are proud to offer scientific opportunities for healthcare professionals working on the field of haematology to present their research and innovations. This includes the chance to submit abstracts for oral and poster presentations, participate in panel discussions, and collaborate with leading researchers in the field. These opportunities will allow both faculty and participants to highlight their scientific contributions and engage with the haematology community on a deeper level.
This year, we are excited to be focusing on themes which have generated buzz in the world of haematology in recent times. Firstly, precision medicine has revolutionised the field of haematology by allowing us to tailor diagnostic and therapeutic strategies for each individual. The deeper understanding of molecular underpinnings of various haematological disorders have allowed for more targeted interventions, and consequently improved outcomes. Another area which has taken the world by storm is artificial intelligence, and haematology is no exception. From boosting diagnostic efficiency to fine-tuning treatment regimens, machine learning algorithms and deep learning models have proven to be useful allies in the battle against haematological diseases. Together, precision medicine and artificial intelligence are but two of the several hot topics that are reshaping our approach to haematology and we are confident that these will be enriching topics for attendees of the ASM.
Join us at the SSH ASM 2026 to collaborate, learn, and shape the future of haematology in Singapore and beyond.
We can't wait to welcome you there!
Dr Lee Shir Ying
President, SSH
Dr Edwin Thong
Co-Chair, SSH ASM 2026
Dr Denise Tan
Co-Chair, SSH ASM 2026
Organised By
Organised By
Sponsorship
For queries related to sponsorship matters, contact our Conference Secretariat Team at secretariat@ssh.org.sg.
Platinum Sponsors
Diamond Sponsors
Gold Sponsors
Registration
Registration Deadline: 18 APR 2026
Registration Form
Are you currently an SSH member?
Yes, I am an existing SSH member.
No, I would like to register as a non-SSH member.
SSH Member Registration
Your SSH Member Email*
Please use a valid SSH member email address.
One-Time Password (OTP)*
Email and OTP do not match. Please try again.
Non-SSH Member Registration
Particulars
Salutation*
Email*
Mobile Number*
Full Name*
Confirm Email*
Profession*
Primary Institution of Practice
Designation*
Institution Name*
Postal Code*
Country / Region*
Department*
Institution Address*
City / State / Province*
MCR/SNB Number*
Please indicate N/A if not applicable.
Email and OTP do not match. Please try again.
Notes
-
Registration are only open to healthcare professionals. Registration seats are limited and are on a first-come-first-serve basis.
-
Confirmation of registration will be issued within 3 to 5 working days, upon receipt of completed Registration Form. If you do not receive the confirmation, please email secretariat@ssh.org.sg for assistance.
-
Any cancellation is to be submitted in writing to the Secretariat at secretariat@ssh.org.sg.
-
Please note that the session may be recorded. If you choose to participate in the session, you are presumed to have consented to the use of your video, audio and text comments in these recordings.
Registration
Registration Deadline: 18 APR 2026
Registration Acknowledgement
Thank you for your registration!
Your registration ID is
SSHASM26-XXX
A registration confirmation email will be sent to the below email address:
<provided email address>
Should you have any clarification, please email secretariat@ssh.org.sg.
Notes
-
Registration seats are limited and are on a first-come-first-serve basis.
-
Confirmation of registration will be issued within 7 to 10 working days, upon receipt of completed Registration Form. If you do not receive the confirmation, please email secretariat@ssh.org.sg for assistance.
-
Any cancellation is to be submitted in writing to the Secretariat at secretariat@ssh.org.sg.
-
Please note that the session may be recorded. If you choose to participate in the session, you are presumed to have consented to the use of your video, audio and text comments in these recordings.
Abstract
Abstract Submission Deadline: 22 MAR 2026 (Closed)
Allied Health Category
Presentation Time: 9 May 2026 (Saturday) 1.00pm - 1.30pm
A-106 Transplant @ Home: A Single Centre Experience In Home-Based Care For Autologous Stem Cell Transplantation
Lee Foong Gwan, National University Cancer Institute, Singapore, National University Hospital, Singapore
A-115 A 5-year Retrospective Analysis of The Use of Extracorporeal Photopheresis (ECP) via UVA-PIT in Treating Graft Versus Host Disease (GVHD) in Singapore General Hospital (SGH)Apheresis Unit
Xie Gaoge, Department of Haematology Centre, Singapore General Hospital, Singapore
A-116 To Reduce the Number of Steps Taken to Check Documents during Blood Transfusion by 50% within 6 Months in Hematology Centre
Chen Juan , Department of Haematology Center, Singapore General Hospital , Singapore
A-117 Multidisciplinary Coordination for Managing the Transition to a New APTT Heparin Therapeutic Range in the Hospital
Jacqueline Lau, National University Health System, Singapore
Clinical Haematology Category
Q&A Time: 9 May 2026 (Saturday) 10.30am - 10.40am
A-101 Relapsed ALK-Positive Anaplastic Large Cell Lymphoma with Durable Disease Control Using Brentuximab, Vedotin and Alectinib
Luke Han Wei-En, Department of Haematology, Singapore General Hospital, Singapore
A-107 Timely Removal of Inferior Vena Cava Filters – Effectiveness and Outcomes of an Active Tracking Process
Jonathan Tang, Department of Haematology, National University Cancer Institute, Singapore
A-113 Nilotinib-Associated Arterial Thrombosis in Chronic Myeloid Leukemia: A Case Series
Parameswary Subramaniam, Department of Haematology, Raja Isteri Pengiran Anak Saleha Hospital, Brunei Darussalam, Brunei
Q&A Time: 9 May 2026 (Saturday) 10.40am - 10.50am
A-119 Characterization of Extramedullary Relapse of Acute Myeloid Leukemia post Allogenic Stem Cell Transplant and Comparison with Marrow Relapse
Seah Si Min, Department of Haematology, Singapore General Hospital, Singapore
A-120 Outcome of Acute Myeloid Leukemia Relapsing After Allogenic Hematopoietic Stem Cell Transplant— Analysis of Risk Factors and Long-Term Clinical Course
Tan Zi Xin Kimberly, Department of Haematology, Singapore General Hospital, Singapore
A-122 Real-World Clinical Characteristics, Treatment Patterns and Outcomes of Classical Hodgkin Lymphoma in a Multi-Ethnic Asian Population: A 15-Year Single-Centre Experience
Roni Wang, Department of Haematology, Natoinal University Hospital, Singapore
Presentation Time: 9 May 2026 (Saturday) 1.00pm - 1.30pm
A-109 Geriatric Assessment Demonstrating Cost-Effectiveness and Improved Survival – A RCT in Haematological Cancers
Melissa Ooi Gaik Ming, National University Hospital, Singapore
A-121 Real-world Asian Multi-centre Cohort Study On Outcomes Of Pola-R-CHP In Untreated Diffuse Large B-cell Lymphoma
Nicole-Ann Lim Shuen, Department of Internal Medicine, Singapore Health Services, Singapore
A-126 The Blinatumomab Era in Philadelphia Chromosome Positive B-Acute Lymphoblastic Leukemia (Ph+ B-ALL): A Single-Center Analysis of Treatment Evolution and Survival
Tan Hui Shan, Valerie, Department of Haematology, Singapore General Hospital, Singapore
A-127 Monospecific and Bispecific Chimeric Antigen Receptor (CAR) T-cell Therapy in Multiple Myeloma: A Systematic Review, Meta-analysis and Meta-regression
Ainsley Ryan Lee Yan Bin, Department of Medicine, National University Hospital, Singapore
Q&A Time: 9 May 2026 (Saturday) 3.30pm - 3.40pm
A-103 Clinical Characteristics and Treatment Outcomes of Acquired Hemophilia A in Singapore: A 10-Year Retrospective Cohort Study
Lee Sz-Ying, Department of Haematology, Singapore General Hospital , Singapore
A-105 NPM1 Mutated Adult Acute Myeloid Leukaemia – Clinicopathological Features, Co-mutational Patterns and Outcomes in Patients Treated at Singapore General Hospital
Christopher Tham Shwei Wen, Singapore General Hospital, Singapore
A-110 Evaluating the Value of Outpatient versus Inpatient High-dose Cytarabine Consolidation in Acute Myeloid Leukemia
Melissa Ooi Gaik Ming, National University Hospital, Singapore
A-123 Real-World Application of Clinical and Molecular-Enhanced Prognostic Scoring Systems in Myelofibrosis Patients in Singapore
Christopher Tham Shwei Wen, Singapore General Hospital, Singapore
A-129 Transitioning from On-Demand to Prophylaxis After Government Subsidies: A Qualitative Study of Beliefs and Behavioural Adaptation in Adult Haemophilia
Lim Xiu Qi Cheryl, Department of Haematology - Oncology, National University Hospital, Singapore
A-131 Parvovirus B19 Induced Pure Red Cell Aplasia in Patient with Systemic Lupus Erythematosus
Lim Jia Yin, Department of Internal Medicine, Ministry of Health
Laboratory and Diagnostic Category
Q&A Time: 9 May 2026 (Saturday) 10.30am - 10.40am
A-102 Comprehensive Analysis of Acute Myeloid Leukaemia with Hyperdiploid Karyotype: An Institutional Case Series and Correlation with Published Cases
Tan Xiu Lin Celine, Department of Laboratory Medicine, NUH, Singapore
A-104 Performance Comparison of the iSED® and iSED® ELITE ESR Analysers
Nurul Atikah Bte Ahmad Salim, Department of Clinical Laboratory, Changi General Hospital, Singapore
Q&A Time: 9 May 2026 (Saturday) 10.40am - 10.50am
A-108 Detection of Heparin Contamination in Prolonged PT/APTT Using a Thrombin Clotting Time Reflex Algorithm: A Retrospective Laboratory Study in Khoo Teck Puat Hospital
Ho Ren How, Department of Laboratory Medicine, Khoo Teck Puat Hospital , Singapore
A-111 A Comparative Evaluation of the Sysmex CN-3000 and CS-2500 Hemostasis Analyzers
Koa Xiangjie, Department of Clinical Laboratory, Changi General Hospital, Singapore
A-124 Analytical Performance Evaluation of Mindray Automated ESR Compared with CUBE30 Touch and Sediplast Systems
Nurul Khaleeda Binte Abdul Mulok, Department of Haematology Laboratory, Singapore General Hospital , Singapore
Presentation Time: 9 May 2026 (Saturday) 1.00pm - 1.30pm
A-112 Evaluation of CellaVision as a Learning Pedagogy for Blood Cell Morphology Training
Ng Shiuh Wen, Department of Laboratory Medicine, Ng Teng Fong General Hospital, Singapore
A-114 Derivation and External Validation of a dRVVT ratio Cutoff for Identifying Triple Positive Antiphospholipid Profiles
Low Yi Hua, Department of Internal Medicine, Singapore General Hospital, Singapore
A-118 Beyond Routine Serology: Discovery of ParaBombay B Phenotype Using Next‑Generation Sequencing
Winarti Chang, Department of Laboratory Medicine, National University Hospital, Singapore
A-128 Evaluation of the VWF Collagen Binding Assay using the HEMOSIL ACUSTAR Analyser
Liu Wen Shan, Singapore General Hospital, Singapore
Q&A Time: 9 May 2026 (Saturday) 3.30pm - 3.40pm
A-125 Analytical Performance Evaluation of Mindray BC-6800 Plus Haematology Analyzer compared with Sysmex XN-9000
Yuki Ong Hui Qi, Department of Haematology Laboratory, Singapore General Hospital, Singapore
A-130 Evaluation of Reference Range for Extended Inflammatory Parameters (EIP)
Goh Jia Hui, Department of Laboratory Medicine, National University Hospital, Singapore
Abstract Submission Instructions
-
Submitted abstracts must be original.
-
All abstracts must be submitted electronically.
-
All abstracts are subject to review by the Scientific Committee and acceptance is not guaranteed.
-
All presenting authors are required to register for the meeting.
-
Accepted Abstracts will be published exactly as submitted on the conference e-booklet and respective authors will be invited for physical Poster Display (only some accepted abstracts will be shortlisted and invited for Poster Presentation).
Abstract Categories
We invite abstract submission for the following categories:
-
Allied Health (Nursing / Pharmacy)
-
Clinical Laboratory and Diagnostic
-
Haematology Trainees (Senior / Junior Resident)
-
Research Laboratory
There will be one Best Poster Award (worth SGD300) and one 1st Runner-Up Poster Award (worth SGD200) for each submission categories.
Important Dates
Abstract Submission Deadline
22 MAR 2026
Notice of Acceptance
24 APR 2026
Poster Display Date
9 MAY 2026
Guidelines for Poster Display
-
The digital version of all accepted abstracts should be shared with the Secretariat prior to printing.
-
All posters must be in English.
-
Poster Template (use of template is not compulsory): Download Link
-
All posters must be printed in A0 portsize (84.1cm × 118.9cm or 33.1" x 46.8") and in portrait format.
-
For easier setup, we would recommend A0 full colour printing on foamboard. If you are using poster paper, please ensure that your poster is uncurled and flattened before setting up.
-
Poster Setup Instructions:
-
Upon registering at the venue, you may proceed to the designated poster display area to set up your abstract.
-
The event personnel at the abstract area would provide you with 4 strips of Velcro tapes.
-
Paste the Velcro tapes at the 4 corners on the back of your physical poster.
-
There will be a poster layout at the venue for you to find your poster board.
-
Once you have found your abstract poster board, paste your physical poster by pressing the 4 corners of your physical poster onto the Poster Panel. Please check that the poster ID on the Poster Panel matches your Poster details before pasting.
-
-
All attendees are invited to view the posters during the meal breaks. We encourage you to stand by your poster during tea and lunch to address enquiries from the attendees.
-
Please remove your poster at the end of the event before 1730 hrs. Kindly note that the venue does not allow poster disposal on-site.
Abstract Submission Form
Presenting Author's Details
Kindly note that all presenting authors are required to register for the meeting. If you haven't registered, please kindly register first.
Registration ID*
Error
Registered Email*
Email and OTP do not match. Please try again.
Presenting Author Particulars
Salutation*
Email*
Full Name*
Mobile Number*
Profession*
Primary Institution of Practice
Designation*
Institution Name*
Postal Code*
Country / Region*
Department*
Institution Address*
City / State / Province*
MCR/SNB Number*
Please indicate N/A if not applicable.
Abstract Details
Abstract Category*
Abstract Title*
Please write the title in Title Case (each main word has a capital letter). Do not use quotation marks. Title should be concise yet descriptive, reflecting the study’s focus.
e.g. The Results of the Research Case Study and Its Participants
Abstract Body*
Text length should NOT exceed 350 words. The text of the abstract should include section headings such as BACKGROUND & AIM, METHODS, RESULTS and CONCLUSION. The section headings should appear in UPPERCASE.
Word Count:
0
Co-Authors' Details
There is no co-author for this abstract.
Full Name*
Department & Institution of Affiliation*
Email*
Country / Region*
Error
Programme
Time
Programme
Speaker
0900 - 0905
Welcome Address
Dr Lee Shir Ying
National University Cancer Institute, Singapore
0905 - 0910
Opening Address
Dr Edwin Thong
National University Cancer Institute, Singapore
MORNING SESSION 1
Chairperson: TBC
0915 - 0945
Session #1
Starting a New Era: Fixed-Duration Bispecific Antibodies in the Precision Management of R/R DLBCL
Prof Chris Fox
University of Nottingham, United Kingdom
0945 - 1015
Session #2
Next-Frontier Therapy: Epcoritamab for 3L+ Follicular Lymphoma
Prof Yeh Su-Peng
China Medical University Hospital, Taiwan
1015 - 1020
Question and Answers
All Speakers
1020 - 1100
Morning Tea Break
-
MORNING SESSION 2
Chairperson: TBC
1100 - 1130
Session #3
Managing Chronic Immune Thrombocytopenia Purpura: Treatment Strategies for Long-Term Disease Control
Dr Liao Chunkai
E-Da Dachung Hospital, Taiwan
1130 - 1200
Session #4
Re-defining Relapse and Refractory Disease in AML through MRD-directed Approach
Dr Sun Loo
The Alfred Hospital & Northern Hospital, Australia
1200 - 1205
Question and Answers
All Speakers
1205 - 1345
Lunch Break
1205 - 1300 SSH Annual General Meeting at Level 1 Auditorium
1205 - 1300 Nursing Track at Level 1 Staff Lounge
1300 - 1330 Poster Presentation
NURSING TRACK
Chairperson: TBC
1205 - 1220
Nursing Talk 1
Anemia, Transfusion, and Alternatives
Ms Nur Diyanah Binte Mohamed Said
National University Cancer Institute, Singapore
1220 - 1235
Nursing Talk 2
Mystic Programme for Patients with Myeloma
Ms Lee Zhao Yuan
Singapore General Hospital, Singapore
1235 - 1250
Nursing Talk 3
VTE and Hyper-coagulation
Ms Shao Zhen Zhi
Singapore General Hospital, Singapore
1250 - 1300
Question and Answers
All Speakers
AFTERNOON KEYNOTE SESSION
Chairperson: TBC
1345 - 1415
Keynote Lecture
Working Toward Cancer Care in 2030:
AI+X for Precision Medicine 2.0, Population Health, Aging and Global Health Impact
Dr Joe Yeong
Singapore General Hospital, SingHealth Duke-NUS Pathology Academic Clinical Programme, Singapore
AFTERNOON SESSION 1
Chairperson: TBC
1415 - 1445
Session #5
Evolving Treatment Strategies in Chronic Lymphocytic Lymphoma and Mantle Cell Lymphoma from ASH 2025
Dr Joanne Lee
Centre For Clinical Haematology, Singapore
1445 - 1515
Session #6
Advances in First-Line Management of MDS-Associated Transfusion-Dependent Anaemia
A/Prof Valeria Santini
University of Florence Medical School, Italy
1515 - 1520
Question and Answers
All Speakers
1520 - 1545
Afternoon Tea Break
-
AFTERNOON SESSION 2
Chairperson: TBC
1545 - 1615
Session #7
Targetting Novel Antigens in RRMM: The Emerging Role of Bispecific Antibodies
Prof Amrita Krishnan
City of Hope, United States
1615 - 1645
Session #8
Navigating the Unmet Needs and Challenges in Early Relapsed Multiple Myeloma
Prof Chng Wee Joo
National University Hospital, Singapore
1645 - 1650
Question and Answers
All Speakers
1650 - 1700
Award Ceremony and Closing Address
Dr Denise Tan
Sengkang General Hospital, Singapore
End of Meeting
Coming Soon
Please check this page again at a later date for more updates.